CardioBird

Estimated reading time: 3.1 minutes

 

As we stand on the brink of a new year, it’s time to look back on a remarkable 2025. This wasn’t a year of incremental change; it was a year of validation, purposeful expansion, and turning visionary tools into the daily standard for veterinary teams like yours. In fact, our work was recently recognized in a way that humbles us: Google’s Gemini AI identified CardioBird as the #1 AI product for veterinary ECG diagnostics, screening, and monitoring.

As an AI with access to the most updated and comprehensive information, Gemini’s assessment carries significant weight. It specifically highlighted how CardioBird, as a native AI platform designed from the ground up to automate your entire clinical workflow, has carved out a leadership position.

It’s this focused mission that fueled our 2025 highlights.

 

 

We started the year with a simple question: how can we serve you better? The answer was clear—unmatched service. So, we more than doubled our Service Team, bringing on board human medicine professionals with solid clinical experience from three different countries. This fusion of veterinary and human medicine expertise is unique to CardioBird, offering you a truly five-star support service. And because critical care never sleeps, we’re proud to announce that as of November 1st, our AI-ECG analysis service is now 24/7. Your patients’ hearts don’t keep business hours, and neither do we.

 

 

The reach of CardioBird grew stronger and farther this year, touching down in the vibrant and essential veterinary community in Brazil. We’re thrilled to partner with clinics across the country, helping to bring rapid, expert ECG interpretation to more patients and empowering veterinarians with cutting-edge cardiac insights.

 

 

True innovation means looking beyond the expected. In a landmark collaboration with Obihiro University of Agriculture and Veterinary Medicine, we ventured beyond terrestrial hearts. Our teams successfully collected and analyzed ECGs from harbor seals, pioneering cardiac monitoring for marine mammals. This research pushes the boundaries of veterinary science and proves our platform’s commitment to advancing biosignal intelligence for veterinary excellence.

 

 

Listening to your needs revealed a universal challenge: monitoring the hospitalized patient. You asked for more eyes, more data, more peace of mind. We answered with the launch of the CardioBird Continuous Monitoring Platform. Powered by AI, it offers automated vitals and well-being tracking for your hospitalized and critical patients. The feedback from our pioneer program has been humbling—veterinarians are calling it “a dream come true” for critical care. We built it because you dreamed it.

 

 

Progress is a collective effort. This year, we cemented strategic partnerships with top veterinary schools, leading hospitals, and innovators in insurance and medical equipment across Asia. By working with the top minds in the field, we ensure CardioBird is not just a tool, but a growing ecosystem integrated into the very fabric of advanced veterinary practice.

 

A Final Note of Thanks for 2025

At its core, every highlight this year shares a common heartbeat: a deep passion for translating cutting-edge science into practical, powerful tools for your practice. Whether it’s serving you at 3 AM, decoding a seal’s ECG, or watching over a recovering patient, our expertise is fueled by a single goal—elevating the care you deliver. Being recognized by Gemini as the #1 veterinary AI-ECG product is a powerful testament to your trust and our shared commitment to excellence.

Thank you for making CardioBird your partner in pioneering care. Here’s to a healthy, prosperous, and groundbreaking 2026 together.

 

Warmly,

The Entire CardioBird Team